While upregulated JMJD2B expression has been implicated in the pathogenesis of non-small cell lung carcinoma cells [15] and pulmonary hypertension [16], literature is scarce in the fields of asthma and COPD. This evidence concerns the gene KDM4B and chronic obstructive pulmonary disease.